• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性低氧增强二甲双胍在小鼠肝癌中的抗肿瘤作用。

Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice.

机构信息

School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.

Agricultural and Health Center, Jiangxi Center for Disease Control and Prevention, Nanchang 330006, China.

出版信息

Acta Biochim Biophys Sin (Shanghai). 2020 Apr 20;52(4):421-429. doi: 10.1093/abbs/gmaa010.

DOI:10.1093/abbs/gmaa010
PMID:32250393
Abstract

Local hypoxia is a universal phenomenon in most solid tumors. The role of local hypoxia in the tumor microenvironment and cancer growth and metastasis has been well established. However, the effect of acute systemic hypoxia (exposing the whole body to 10% O2 environment) on cancer has not yet been investigated. In this study, we investigated the potential effects of acute systemic hypoxia itself and in combination with metformin on hepatocellular carcinoma (HCC) growth and metastasis in a mouse model of HCC. Acute systemic hypoxia significantly decreased tumor volume and weight in H22 tumor-bearing mice. Interestingly, the combined treatment of acute systemic hypoxia and metformin showed a more pronounced effect in reducing tumor volume and weight. Moreover, acute systemic hypoxia and metformin in combination had a potent inhibitory effect on tumor progression. More importantly, the expressions of hypoxia response genes including hypoxia-inducible factor-1 α, vascular endothelial growth factor, and matrix metalloproteinase 2 were significantly decreased in the tumor tissues with combination treatment. Our study demonstrated that acute systemic hypoxia repressed tumor progression of the HCC and potentiated the anti-tumor activities of metformin. This study supports that combination of systemic hypoxia and metformin treatment may represent a novel strategy for HCC.

摘要

局部缺氧是大多数实体瘤中普遍存在的现象。局部缺氧在肿瘤微环境以及癌症生长和转移中的作用已得到充分证实。然而,急性全身缺氧(将整个身体暴露在 10%氧气环境中)对癌症的影响尚未得到研究。在这项研究中,我们研究了急性全身缺氧本身以及与二甲双胍联合应用对肝癌(HCC)在 HCC 小鼠模型中生长和转移的潜在影响。急性全身缺氧可显著降低 H22 荷瘤小鼠的肿瘤体积和重量。有趣的是,急性全身缺氧与二甲双胍联合治疗在减轻肿瘤体积和重量方面表现出更显著的效果。此外,急性全身缺氧与二甲双胍联合应用对肿瘤进展具有强大的抑制作用。更重要的是,在联合治疗的肿瘤组织中,缺氧反应基因(包括缺氧诱导因子-1α、血管内皮生长因子和基质金属蛋白酶 2)的表达明显降低。我们的研究表明,急性全身缺氧抑制了 HCC 的肿瘤进展,并增强了二甲双胍的抗肿瘤活性。这项研究支持全身缺氧与二甲双胍联合治疗可能是 HCC 的一种新策略。

相似文献

1
Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice.系统性低氧增强二甲双胍在小鼠肝癌中的抗肿瘤作用。
Acta Biochim Biophys Sin (Shanghai). 2020 Apr 20;52(4):421-429. doi: 10.1093/abbs/gmaa010.
2
Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma.二甲双胍通过重编程肝细胞癌中的氧代谢来抑制缺氧诱导的HIF-1α稳定。
Oncotarget. 2016 Jan 5;7(1):873-84. doi: 10.18632/oncotarget.6418.
3
Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.二甲双胍可使索拉非尼在原位小鼠模型中更有效地抑制肝细胞癌术后复发和转移。
J Hematol Oncol. 2016 Mar 8;9:20. doi: 10.1186/s13045-016-0253-6.
4
Metformin Enhances the Effect of Regorafenib and Inhibits Recurrence and Metastasis of Hepatic Carcinoma After Liver Resection via Regulating Expression of Hypoxia Inducible Factors 2α (HIF-2α) and 30 kDa HIV Tat-Interacting Protein (TIP30).二甲双胍通过调节低氧诱导因子 2α(HIF-2α)和 30 kDa HIV Tat 相互作用蛋白(TIP30)的表达增强瑞戈非尼的疗效并抑制肝切除术后肝癌的复发和转移。
Med Sci Monit. 2018 Apr 14;24:2225-2234. doi: 10.12659/msm.906687.
5
Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.缺氧诱导因子-1α/白细胞介素-1β 信号通过巨噬细胞增强低氧炎症微环境中的肝癌上皮-间充质转化。
Hepatology. 2018 May;67(5):1872-1889. doi: 10.1002/hep.29681. Epub 2018 Mar 26.
6
HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.在缺氧肿瘤微环境中,缺氧诱导因子-1α(HIF-1α)通过上调赖氨酰氧化酶样蛋白2(LOXL2)促进肝细胞癌中的血管生成拟态形成。
J Exp Clin Cancer Res. 2017 Apr 27;36(1):60. doi: 10.1186/s13046-017-0533-1.
7
ATXN7L3B promotes hepatocellular carcinoma stemness and is downregulated by metformin.ATXN7L3B 促进肝癌干细胞特性,并受二甲双胍下调。
Biochem Biophys Res Commun. 2021 Oct 8;573:1-8. doi: 10.1016/j.bbrc.2021.08.009. Epub 2021 Aug 6.
8
Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.缺氧介导的索拉非尼耐药可以通过 EF24 克服,EF24 通过 Von Hippel-Lindau 肿瘤抑制因子依赖性 HIF-1α 抑制在肝细胞癌中发挥作用。
Hepatology. 2013 May;57(5):1847-57. doi: 10.1002/hep.26224. Epub 2013 Mar 14.
9
Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.索拉非尼诱导的HIF-2α上调通过激活肝癌细胞中的TGF-α/EGFR途径导致耐药。
Cell Signal. 2014 May;26(5):1030-9. doi: 10.1016/j.cellsig.2014.01.026. Epub 2014 Jan 29.
10
Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.二甲双胍通过下调ERK/JNK介导的NF-κB依赖性途径抑制人肝癌细胞的侵袭,并增强对索拉非尼的化学敏感性,该途径可降低尿激酶型纤溶酶原激活剂(uPA)和基质金属蛋白酶-9(MMP-9)的表达。
Amino Acids. 2014 Dec;46(12):2809-22. doi: 10.1007/s00726-014-1838-4. Epub 2014 Sep 23.

引用本文的文献

1
Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells.低氧微环境对肺癌细胞中二甲双胍、咖啡因和二氯乙酸钠抗肿瘤反应的调节作用
Int J Mol Sci. 2025 May 23;26(11):5014. doi: 10.3390/ijms26115014.
2
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?二甲双胍在肝细胞癌治疗中的新作用:将二甲双胍重新用于肝癌免疫治疗有价值吗?
Cancers (Basel). 2023 Jun 13;15(12):3161. doi: 10.3390/cancers15123161.